These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Surgery of the recurrent laryngeal nerve for spastic dysphonia. Som ML; Biller HF Ann Otol Rhinol Laryngol; 1977; 86(3 Pt 1):411. PubMed ID: 869444 [No Abstract] [Full Text] [Related]
32. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia. Tsuji DH; Chrispim FS; Imamura R; Sennes LU; Hachiya A Braz J Otorhinolaryngol; 2006; 72(2):261-6. PubMed ID: 16951863 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin injection for adductor spastic dysphonia: patient self-ratings of voice and phonatory effort after three successive injections. Aronson AE; McCaffrey TV; Litchy WJ; Lipton RJ Laryngoscope; 1993 Jun; 103(6):683-92. PubMed ID: 8502104 [TBL] [Abstract][Full Text] [Related]
34. Lidocaine block of the recurrent laryngeal nerve in adductor spasmodic dysphonia: a multidimensional assessment. Smith ME; Roy N; Wilson C Laryngoscope; 2006 Apr; 116(4):591-5. PubMed ID: 16585864 [TBL] [Abstract][Full Text] [Related]
38. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics. Davis PJ; Boone DR; Carroll RL; Darveniza P; Harrison GA Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):179-85. PubMed ID: 3355046 [TBL] [Abstract][Full Text] [Related]
39. Treatment of spasmodic dysphonia by means of resection of the recurrent laryngeal nerve. Schiratzki H; Fritzell B Acta Otolaryngol Suppl; 1988; 449():115-7. PubMed ID: 3201933 [TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section. Sulica L; Blitzer A; Brin MF; Stewart CF Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]